EUVIMEDEUVIMED entdecken
Crossref

Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021

Stefano Amadesi, Marta Palombo, Federica Bovo, Andrea Liberatore, Elena Vecchi, Monica Cricca, Tiziana Lazzarotto, Simone Ambretti, Paolo Gaibani iD

Microbial Drug Resistance · 2024

DOI: 10.1089/mdr.2023.0150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Drug Resistance, 2024. Verfasst von Stefano Amadesi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Operative Unit of Clinical Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Antifungal Agents, Candidiasis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Candida auris is a concerning pathogen in health care due to its ability to spread in medical settings. In this study, we characterized the genome of three C. auris clinical isolates collected in the Emilia-Romagna region of Northeastern Italy from January 2020 to May 2021. Whole-genome sequencing was performed using Illumina iSeq 100 and Oxford Nanopore MinION systems. Genomes were assembled with Flye. Phylogenetic analysis was carried out with RaxML. The ERG 11 , TAC1b , and FKS1 genes were examined for known substitutions associated with resistance to azoles and caspofungin using Diamond. All three C. auris isolates belonged to clade I (South Asian lineage) and showed high minimum inhibitory concentrations for fluconazole. Two of the three isolates were closely related to the first Italian index case of C. auris occurred in the 2019 and carried similar mutations associated to azole resistance. The third isolate showed a greater phylogenetic distance from these strains and had a different genetic determinant not previously seen in Italy. Our data suggest that two C. auris clinical isolates may have been epidemiologically related to the first outbreak previously observed in Italy, while the remaining isolate may have originated from a different source. Further research is needed to understand C. auris transmission and resistance and to control its spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsCandidiasisHumansCandidaCandida aurisPhylogenyDrug Resistance, FungalMicrobial Sensitivity TestsAnti-Bacterial AgentsAzoles

Stichwörter der Autor:innen

Italyazole resistanceclade Ioutbreakwhole-genome sequencing

Substanzen

Antifungal AgentsAnti-Bacterial AgentsAzoles

Autor:innen und Institutionen

  • Operative Unit of Clinical Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Public Health of Emilia-Romagna Region, Bologna, Italy.
  • DIMEC, University of Bologna, Bologna, Italy.

ORCID-Profile: Paolo Gaibani

Zitieren

APA

Amadesi, S., Palombo, M., Bovo, F., Liberatore, A., Vecchi, E., Cricca, M., Lazzarotto, T., Ambretti, S., & Gaibani, P. (2024). Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2023.0150

Vancouver

Amadesi S, Palombo M, Bovo F, Liberatore A, Vecchi E, Cricca M, et al. Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021. Microbial Drug Resistance. 2024. doi:10.1089/mdr.2023.0150

BibTeX
@article{Amadesi2024,
  author = {Amadesi, Stefano and Palombo, Marta and Bovo, Federica and Liberatore, Andrea and Vecchi, Elena and Cricca, Monica and Lazzarotto, Tiziana and Ambretti, Simone and Gaibani, Paolo},
  title = {Clonal Dissemination of Candida auris Clinical Isolates in Northern Italy, 2021},
  journal = {Microbial Drug Resistance},
  year = {2024},
  doi = {10.1089/mdr.2023.0150}
}
Kostenlos starten →